Collaboration to validate next-generation tests for detection of primary and recurrent/metastatic cancer and personalized treatment response prediction. Partnership aims to enhance precision oncology through advanced novel biomarker-driven diagnostics. HealthCare Global Enterprises Limited (HCG), India’s leading provider of cancer care announced a research collaboration with Trucan